A detailed history of Howard Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Howard Wealth Management, LLC holds 1,861 shares of ABBV stock, worth $320,687. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,861
Previous 1,805 3.1%
Holding current value
$320,687
Previous $279,000 21.15%
% of portfolio
0.27%
Previous 0.23%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $8,949 - $10,197
56 Added 3.1%
1,861 $338,000
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $47,836 - $59,528
-361 Reduced 16.67%
1,805 $243,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $11,858 - $13,656
-82 Reduced 3.65%
2,166 $345,000
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $7,053 - $8,459
-51 Reduced 2.22%
2,248 $0
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $308,548 - $353,885
2,299 New
2,299 $308,000
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $303,452 - $385,786
-2,205 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $3,827 - $4,748
29 Added 1.33%
2,205 $357,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $20,411 - $25,826
190 Added 9.57%
2,176 $294,000
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $425 - $483
4 Added 0.2%
1,986 $214,000
Q2 2021

Jul 27, 2021

SELL
$105.21 - $117.21 $2,630 - $2,930
-25 Reduced 1.25%
1,982 $223,000
Q1 2021

Apr 23, 2021

SELL
$102.3 - $112.62 $9,207 - $10,135
-90 Reduced 4.29%
2,007 $217,000
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $168,787 - $227,880
2,097 New
2,097 $224,000
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $118,486 - $179,640
-1,837 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $132,502 - $165,789
1,837 New
1,837 $162,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $305B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Howard Wealth Management, LLC Portfolio

Follow Howard Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howard Wealth Management, LLC with notifications on news.